Items where Author is "Rolink, A."
Jump to: Yes Number of items: 5. YesHarmeier, A. and Obermueller, S. and Meyer, C. A. and Revel, F. G. and Buchy, D. and Chaboz, S. and Dernick, G. and Wettstein, J. G. and Iglesias, A. and Rolink, A. and Bettler, B. and Hoener, M. C.. (2015) Trace amine-associated receptor 1 activation silences GSK3β signaling of TAAR1 and D2R heteromers. European Neuropsychopharmacology, 25 (11). pp. 2049-2061. Fazio, G. and Cazzaniga, V. and Palmi, C. and Galbiati, M. and Giordan, M. and te Kronnie, G. and Rolink, A. and Biondi, A. and Cazzaniga, G.. (2013) PAX5/ETV6 alters the gene expression profile of precursor B cells with opposite dominant effect on endogenous PAX5. Leukemia, Vol. 27, no. 4. pp. 992-995. Fazio, G. and Palmi, C. and Rolink, A. and Biondi, A. and Cazzaniga, G.. (2008) PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells. Cancer research, 68,1. pp. 181-189. Bosco, N. and Ceredig, R. and Rolink, A.. (2008) Transient decrease in interleukin-7 availability arrests B lymphopoiesis during pregnancy. European Journal of Immunology, Vol. 38, H. 2. pp. 381-390. Günthert, U. and Schwärzler, C. and Wittig, B. and Laman, J. and Ruiz, P. and Stauder, R. and Bloem, A. and Smadja-Joffe, F. and Zöller, M. and Rolink, A.. (1998) Functional involvement of CD44, a family of cell adhesion molecules, in immune responses, tumour progression and haematopoiesis. Advances in experimental medicine and biology, Vol. 451. pp. 43-49. |
